Throat chlamydia is treated with a course of oral antibiotics, typically doxycycline taken twice daily for seven days. The infection is curable, but treating it in the throat is slightly trickier than treating genital chlamydia because the bacteria can be harder to clear from the oropharynx. Most people with pharyngeal chlamydia have no symptoms at all, which means many cases go undiagnosed and untreated unless specifically tested for.
Why Doxycycline Is Preferred Over a Single Dose
For genital chlamydia, a one-time dose of azithromycin used to be the go-to treatment. That’s changed. The CDC now recommends doxycycline as the first-line option for chlamydia infections across all body sites, and this matters even more for throat infections. Observational data indicates doxycycline is more effective than azithromycin for clearing chlamydia from the oropharynx. For rectal chlamydia, a related comparison, doxycycline achieved a 100% cure rate versus 74% for azithromycin in a randomized trial. While those numbers aren’t directly from throat-specific studies, they illustrate why a seven-day course of doxycycline is preferred over a single-dose approach when the infection sits outside the genital tract.
The standard regimen is 100 mg of doxycycline taken by mouth twice a day for seven days. You need to complete the full course even if you feel fine, since most people with throat chlamydia don’t have symptoms to begin with. Skipping doses or stopping early increases the chance the infection won’t fully clear.
Most Throat Infections Cause No Symptoms
The vast majority of pharyngeal chlamydia infections are completely silent. The World Health Organization notes that oral chlamydia is “most often without symptoms.” When symptoms do appear, they can include a mild sore throat, slight redness in the back of the throat, or occasionally swollen lymph nodes in the neck. These signs are vague enough to be mistaken for a common cold or allergies, which is why throat chlamydia is rarely caught based on symptoms alone.
This is worth understanding because it changes how you should think about testing. If you’ve had unprotected oral sex with a new or untested partner, the absence of a sore throat doesn’t mean much. The infection can still be present, still transmissible, and still worth treating.
How Throat Chlamydia Is Diagnosed
Throat chlamydia is diagnosed with a simple swab of the back of your throat. The swab is tested using a nucleic acid amplification test (NAAT), which detects the bacteria’s genetic material. This is the same type of highly sensitive test used for genital chlamydia, and it’s far more accurate than older culture methods for catching throat infections. In one study comparing different testing approaches for oropharyngeal chlamydia, a NAAT called AC2 detected 100% of infections, while traditional culture only caught 44%.
Standard STI screening panels typically test urine or genital swabs, not the throat. If you’re at risk for oral transmission, you need to specifically ask for a throat swab. This is especially important for men who have sex with men, who are more routinely screened at multiple body sites, but anyone who has had oral sex can acquire pharyngeal chlamydia.
How It Spreads and Who’s at Risk
Throat chlamydia is acquired through giving oral sex to an infected partner. The bacteria colonize the tissue of the oropharynx, though generally at a lower bacterial load than what’s seen in genital or rectal infections. The viability of the bacteria in the throat also appears to be somewhat diminished compared to other sites, which means the throat may be a less efficient source of onward transmission. That said, male-to-female transmission of chlamydia via oral sex has been documented, so a throat infection isn’t harmless just because it’s often asymptomatic.
Pharyngeal chlamydia frequently occurs alongside genital or rectal chlamydia. If you test positive at one site, testing other sites where exposure may have occurred is a practical step to ensure nothing is missed.
What to Expect During and After Treatment
Doxycycline is taken with food and a full glass of water, ideally while sitting or standing upright, since it can irritate the esophagus if it doesn’t make it all the way to your stomach. Avoid lying down for at least 30 minutes after taking it. The medication can also increase sun sensitivity, so you may burn more easily during the week you’re on it.
You should avoid all oral, vaginal, and anal sexual contact until you’ve completed the full seven-day course. If you were given a single-dose alternative for any reason, the standard recommendation for genital chlamydia is to wait at least seven days after that dose before resuming sexual activity. These timelines exist to prevent passing the infection to a partner before the antibiotics have fully done their job.
Because evidence on the effectiveness of antibiotics for throat chlamydia is more limited than for genital infections, a follow-up test to confirm the infection has cleared is a reasonable step. This is typically done about four weeks after finishing treatment. Testing too early can produce a false positive because the NAAT is sensitive enough to pick up dead bacterial DNA that hasn’t yet been cleared from your tissues.
Notifying Sexual Partners
Anyone you’ve had sexual contact with in the 60 days before your diagnosis should be notified so they can get tested and treated. This includes partners who received oral sex from you, since they may have a genital infection even if your only positive site was the throat. In some states, expedited partner therapy is available, meaning your prescriber can write a prescription for your partner without examining them directly. This option is most commonly used for heterosexual partners with chlamydia or gonorrhea and may not be available everywhere or for every situation, but it’s worth asking about if your partner faces barriers to getting their own appointment quickly.
Reinfection is common with chlamydia, and it usually happens because a sexual partner wasn’t treated at the same time. Completing your own antibiotics won’t protect you if you’re re-exposed by an untreated partner shortly afterward. Retesting about three months after treatment catches these reinfections early.